JNT-517 Placebo, JNT-517, JNT-517
JNT517-301
Phase 3 small_molecule active
Quick answer
JNT-517 Placebo, JNT-517, JNT-517 for Phenylketonuria is a Phase 3 program (small_molecule) at Otsuka Novel Products GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Novel Products GmbH
- Indication
- Phenylketonuria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active